Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence.
Recombinant viruses between the virulent Mahoney and attenuated Sabin 1 strains of poliovirus type 1 were subjected to neurovirulence tests using a transgenic (Tg) mouse line, ICR-PVRTg1, that carried the human poliovirus receptor gene. The Tg mice were inoculated intracerebrally with these recombinant viruses and observed for clinical signs, histopathological lesions, and viral antigens as parameters of neurovirulence of the viruses. These parameters observed in the Tg mice were different for different inoculated viruses. Dose-dependent incidences of paralysis and of death were observed in the Tg mice inoculated with any viruses used. This indicates that values of 50% lethal dose are useful to score a wide range of neurovirulence of poliovirus. The neurovirulence of individual viruses estimated by the Tg mouse model had a strong correlation with those estimated by monkey model. Consequently, the mouse tests identified the neurovirulence determinants on the genome of poliovirus that had been identified by monkey tests. In addition, the mouse tests revealed new neurovirulence determinants, that is, different nucleotides between the two strains at positions 189 and 21 and/or 935 in the 5'-proximal 1,122 nucleotides. The Tg mice used in this study may be suitable for replacing monkeys for investigating poliovirus neurovirulence.
Horie
H
H
Department of Microbiology, Tokyo Metropolitan Institute of Medical Science, Japan.
Koike
S
S
Kurata
T
T
Sato-Yoshida
Y
Y
Ise
I
I
Ota
Y
Y
Abe
S
S
Hioki
K
K
Kato
H
H
Taya
C
C
D000818:Animals; D000956:Antigens, Viral / Q000302:isolation & purification; D002490:Central Nervous System / Q000473:pathology*; D004195:Disease Models, Animal; D005260:Female; D000882:Haplorhini / Q000382:microbiology; D007150:Immunohistochemistry; D007928:Lethal Dose 50; D008297:Male; D008565:Membrane Proteins; D051379:Mice; D008822:Mice, Transgenic / Q000382:microbiology*; D010641:Phenotype; D011051:Poliomyelitis / Q000473:pathology*; D017955:Poliovirus / Q000235:genetics / Q000472:pathogenicity*; D011055:Poliovirus Vaccine, Oral; D011991:Receptors, Virus / Q000235:genetics*; D013045:Species Specificity; D014774:Virulence / Q000235:genetics
D000956:Antigens, Viral; D008565:Membrane Proteins; D011055:Poliovirus Vaccine, Oral; D011991:Receptors, Virus; C066100:poliovirus receptor